Agile Therapeutics Stock Price, News & Analysis
Company Description
Agile Therapeutics (OTC: AGRX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
AGRX stock has declined 100.0% over the past year. Shares last traded at $1.51.
This page provides a comprehensive overview of AGRX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Agile Therapeutics (AGRX) stock last traded at $1.51. Over the past 12 months, the stock has lost 100.0%.
Latest News
Agile Therapeutics has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include acquisition, earnings, conferences, offering. View all AGRX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AGRX Company Profile & Sector Positioning
Agile Therapeutics (AGRX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.